Xylem (XYL) Scheduled to Post Earnings on Wednesday

Xylem (NYSE:XYLGet Rating) is set to issue its quarterly earnings data before the market opens on Wednesday, May 4th. Analysts expect the company to announce earnings of $0.43 per share for the quarter. Xylem has set its FY22 guidance at $2.35-$2.70 EPS.Parties that are interested in participating in the company’s conference call can do so using this link.

Xylem (NYSE:XYLGet Rating) last posted its quarterly earnings data on Thursday, February 3rd. The industrial products company reported $0.63 EPS for the quarter, beating the Zacks’ consensus estimate of $0.62 by $0.01. Xylem had a net margin of 8.22% and a return on equity of 14.67%. The company had revenue of $1.32 billion for the quarter, compared to analyst estimates of $1.31 billion. During the same period in the prior year, the firm posted $0.81 EPS. The company’s quarterly revenue was down 3.6% on a year-over-year basis. On average, analysts expect Xylem to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Xylem stock opened at $80.81 on Wednesday. The company has a quick ratio of 1.77, a current ratio of 2.27 and a debt-to-equity ratio of 0.76. Xylem has a 12-month low of $80.80 and a 12-month high of $138.78. The firm’s fifty day moving average is $86.53 and its 200 day moving average is $106.46. The company has a market capitalization of $14.55 billion, a PE ratio of 34.39, a PEG ratio of 2.86 and a beta of 1.11.

The business also recently announced a quarterly dividend, which was paid on Thursday, March 17th. Investors of record on Thursday, February 17th were given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.48%. The ex-dividend date was Wednesday, February 16th. This is an increase from Xylem’s previous quarterly dividend of $0.28. Xylem’s payout ratio is presently 51.06%.

XYL has been the topic of a number of research reports. Raymond James upgraded shares of Xylem from an “underperform” rating to a “market perform” rating in a research report on Tuesday, April 5th. Credit Suisse Group lowered their price objective on shares of Xylem from $111.00 to $98.00 and set an “underperform” rating on the stock in a report on Friday, February 4th. Zacks Investment Research upgraded shares of Xylem from a “strong sell” rating to a “hold” rating and set a $92.00 price objective on the stock in a report on Wednesday, April 6th. Morgan Stanley lowered their price objective on shares of Xylem from $120.00 to $110.00 and set an “overweight” rating on the stock in a report on Monday, April 18th. Finally, StockNews.com started coverage on shares of Xylem in a report on Thursday, March 31st. They set a “hold” rating on the stock. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, Xylem currently has an average rating of “Hold” and a consensus target price of $114.45.

In other news, SVP Colin R. Sabol sold 4,233 shares of the company’s stock in a transaction on Monday, April 18th. The shares were sold at an average price of $83.05, for a total value of $351,550.65. Following the completion of the sale, the senior vice president now owns 27,373 shares in the company, valued at approximately $2,273,327.65. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.89% of the company’s stock.

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Deutsche Bank AG grew its position in Xylem by 1.7% during the fourth quarter. Deutsche Bank AG now owns 1,198,452 shares of the industrial products company’s stock valued at $143,719,000 after buying an additional 20,522 shares during the period. California State Teachers Retirement System boosted its position in Xylem by 1.6% during the fourth quarter. California State Teachers Retirement System now owns 323,159 shares of the industrial products company’s stock worth $38,753,000 after purchasing an additional 5,094 shares during the period. Barclays PLC boosted its position in Xylem by 5.2% during the fourth quarter. Barclays PLC now owns 237,369 shares of the industrial products company’s stock worth $28,466,000 after purchasing an additional 11,642 shares during the period. Stifel Financial Corp boosted its position in Xylem by 0.9% during the fourth quarter. Stifel Financial Corp now owns 99,274 shares of the industrial products company’s stock worth $11,906,000 after purchasing an additional 863 shares during the period. Finally, Metropolitan Life Insurance Co NY boosted its position in Xylem by 2.3% during the fourth quarter. Metropolitan Life Insurance Co NY now owns 25,925 shares of the industrial products company’s stock worth $3,109,000 after purchasing an additional 591 shares during the period. Institutional investors own 83.99% of the company’s stock.

About Xylem (Get Rating)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications in the United States, Europe, the Asia Pacific, and internationally. It operates through three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions.

Further Reading

Earnings History for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.